Does the VA cover Wegovy, and what it takes to qualify

The VA can make Wegovy available for weight management, but it is not an automatic benefit. At the VA, semaglutide is available nonformulary with criteria for use [2]. The common gate is participation in a structured lifestyle intervention program, such as MOVE!, plus a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity [1]. Your VA care team applies the criteria and makes the decision. Being enrolled in MOVE! gets you into the documented process. It does not decide the outcome by itself.

Is Wegovy available through the VA?

Yes, semaglutide is available through the VA for weight management, but the formulary label matters. The VA lists liraglutide, semaglutide, and tirzepatide as available nonformulary with criteria for use [2]. Wegovy is the semaglutide product associated with weight management in the question you are asking.

Nonformulary does not mean the drug is absent from the VA system. It means the medication is outside the standard formulary list and has a defined review path. The criteria for use are the gate. Your care team checks whether your clinical record fits the common VA requirements and any additional criteria that apply to the medication [1].

That is different from walking into an appointment and asking for a specific product with no supporting record. The VA expects weight management medications to be used with a structured lifestyle intervention program that addresses nutrition, physical activity, and behavior [1]. MOVE! is the VA weight management program for veterans and offers that kind of lifestyle program [1].

The practical answer is narrow. You have a documented path to ask about Wegovy if you are already in MOVE!, but the VA care team has the final word. The VA criteria and your record decide whether the request fits.

If you are comparing this question with another GLP-1, read does the VA cover Ozempic. The VA coverage hub collects the related program rules without mixing VA criteria with family member coverage.

What does nonformulary with criteria for use mean?

A formulary is the list of medications a health program keeps available under its standard rules. Nonformulary means a medication sits outside that standard list. With criteria for use means the VA has written conditions for when the medication can be considered. It is not the same as not covered, and it is not the same as available on request.

For Wegovy, the criteria begin with the VA's common requirements for weight management medications. You need participation in a structured lifestyle intervention program, which the VA calls a CLI, and you need to meet the applicable BMI threshold [1]. A CLI targets nutrition, physical activity, and behavior [1].

The BMI paths are distinct. One path is a BMI of 30 or higher. The other is a BMI of 27 or higher with at least one weight-related comorbidity [1]. A comorbidity is a related health condition that the VA lists as relevant to the weight management decision.

The record still matters. Your MOVE! enrollment can document participation in the lifestyle program. Your clinical record can document a measured BMI and a diagnosis. The care team then reviews the request under the criteria for use. The published criteria do not turn enrollment into an automatic medication decision [1].

This is why the phrase matters when you speak with your care team. Ask whether your current MOVE! participation and medical record meet the Wegovy criteria for use. Do not treat nonformulary status as a final no, and do not treat it as a yes.

What does the VA require before it considers Wegovy?

The common VA criteria have 2 parts. First, you participate in a structured lifestyle intervention program. Second, you meet one of the BMI paths, either a BMI of 30 or higher, or a BMI of 27 or higher with at least one listed weight-related comorbidity [1].

The VA's comorbidity examples include hypertension, type 2 diabetes, dyslipidemia, metabolic syndrome, obstructive sleep apnea, osteoarthritis, and MASLD [1]. The list gives your care team a documented clinical basis to review. It does not mean any condition automatically results in Wegovy.

The VA also says each medication has additional criteria of its own, alongside common exclusions such as pregnancy, breastfeeding, and a hypersensitivity reaction to the medication [1]. The care team must consider those medication-specific requirements as part of the review.

That gives you a useful way to prepare. Do not rely on a remembered number from an old appointment. Ask for the BMI measurement in the current record or ask the care team to measure it. If you are using the BMI of 27 or higher path, make sure the relevant diagnosis is documented in your VA record. A condition you mention casually may not be the same as a diagnosis the care team can use in the review.

The VA GLP-1 criteria for use guide goes deeper into the broader VA process. The official VA criteria remain the controlling source for your request.

Does MOVE! satisfy the VA lifestyle requirement?

MOVE! is the most direct VA program to bring into this conversation. The VA describes MOVE! as its weight management program for veterans and says it offers an evidence-based lifestyle program that has helped hundreds of thousands of veterans [1]. The VA also says weight management medications should be used together with a CLI, such as MOVE! or a community-based program that offers one [1].

If you are already enrolled in MOVE!, keep the enrollment information and participation record available for your appointment. You can ask your care team whether your current participation documents the CLI part of the criteria. That is a concrete question, not a request for the care team to skip the review.

MOVE! enrollment is still one part of the record. Your care team must also review the BMI requirement and any weight-related comorbidity. The common criteria do not say that MOVE! enrollment alone meets the medication requirements [1].

The VA's approach also explains why a medication request may lead back to the program you already joined. The lifestyle intervention is not separate from the medication criteria. It is part of the structure the VA uses when it considers weight management medications [1].

You do not need to guess which paperwork matters. Bring your MOVE! enrollment details, ask whether your participation is recorded as a CLI, and ask what BMI and diagnosis documentation the care team still needs.

How does this differ from CHAMPVA coverage?

A veteran receiving VA care and a family member using CHAMPVA are in different programs. CHAMPVA is the health care program for the spouse or widow or widower and children of an eligible veteran [3]. A CHAMPVA spouse does not use the veteran's VA criteria for a weight management medication.

CHAMPVA does not cover GLP-1 medications prescribed for weight loss [3]. Its program page documents narrower covered uses. For type 2 diabetes, CHAMPVA covers Mounjaro, Ozempic, Rybelsus, Trulicity, and Victoza. For moderate to severe obstructive sleep apnea verified by a sleep study within the past 12 months, it covers Zepbound. It covers Wegovy for MASH or prevention of MACE [3].

CHAMPVA requires prior authorization for Wegovy and Zepbound, and requests go to OptumRx at 844-403-1029 [3]. That is a CHAMPVA process, not a step for a veteran asking the VA about Wegovy for weight management.

The distinction is easy to lose because the medication names overlap. The program does not. Your VA care team applies VA criteria. A CHAMPVA member follows the CHAMPVA program page and its prior authorization process. The official program source has the final word in either case.

Here is the VA request in a form you can use at your appointment:

What to do next

Written for a veteran already in MOVE! and checking the Wegovy question this week:

1. Open your MOVE! enrollment record and save the participation details for your VA appointment.
2. Ask your VA care team whether your MOVE! participation is documented as the CLI required for weight management medications [1].
3. Ask for the current measured BMI in your VA record, rather than relying on an older measurement.
4. If your BMI is 27 or higher and below 30, ask which documented weight-related comorbidity applies in your record [1].
5. Gather diagnosis records for hypertension, type 2 diabetes, dyslipidemia, metabolic syndrome, obstructive sleep apnea, osteoarthritis, or MASLD if one applies [1].
6. Ask the care team to review semaglutide under the VA criteria for use, including any additional medication-specific criteria [1].
7. Read the VA GLP-1 criteria for use guide before the appointment and compare it with your MOVE! and diagnosis records.
8. Ask for the decision and any missing documentation in your VA record, then check the official VA source before acting on an answer from a third party.

Sources

1. VA PBM Academic Detailing, Weight Management A VA Clinician Summary (2025), VA criteria for use, CLI participation, MOVE!, BMI thresholds, and comorbidities, accessed 2026-08-01, https://www.pbm.va.gov/PBM/AcademicDetailingService/Documents/508/IB10-1784_WeightMgmt-ClinicianSummary_P97235.pdf
2. U.S. Medicine, 2025 Compendium of Federal Medicine, weight loss medications for veterans, VA nonformulary status for semaglutide, accessed 2026-08-01, https://www.usmedicine.com/2025-compendium-of-federal-medicine/determining-what-weight-loss-medications-are-best-for-veterans/
3. VA Community Care, CHAMPVA program page, GLP-1 coverage rules, CHAMPVA indications and OptumRx prior authorization, accessed 2026-08-01, https://department.va.gov/vha/community-care/family-member-care/champva/